文献速递哮喘呼吸道感染

重症哮喘合并气道感染患者中自身抗体介导的巨噬细胞功能障碍

Autoantibody-mediated Macrophage Dysfunction in Patients with Severe Asthma with Airway Infections.
PubMed 文献 · Am J Respir Crit Care Med · 2023-01-01

本研究在143例重度哮喘患者中检测痰液抗MARCO IgG,发现36%患者阳性且与混合粒细胞痰、感染标志物及细胞因子相关;抗MARCO抗体阳性者后续感染性急性加重风险更高;体外实验显示该抗体可降低巨噬细胞细菌摄取及IL-10、GM-CSF释放。

要点

  • 重度哮喘患者痰中抗MARCO IgG阳性率36%,与混合粒细胞痰和感染相关。
  • 抗MARCO抗体阳性者后续感染性急性加重风险高于嗜酸性急性加重。
  • 该抗体可抑制巨噬细胞细菌摄取及LPS诱导的IL-10、GM-CSF释放。

核心结论

  • 嗜酸性哮喘气道中的抗巨噬细胞清道夫受体自身抗体可能损害宿主防御并导致反复感染性支气管炎。

研究设计与样本

  • 研究检测了143例特征明确的重度哮喘患者的221份痰液中的抗EPX、抗MARCO IgG滴度及T1/T2细胞因子。
  • 体外用从高抗MARCO滴度痰液中免疫沉淀的免疫球蛋白处理健康对照外周单核细胞和单核细胞来源巨噬细胞,评估肺炎链球菌摄取及LPS反应。

主要发现

  • 36%患者检测到抗MARCO IgG,混合粒细胞痰患者滴度显著更高(高达1:16)。
  • 多变量回归分析显示抗MARCO IgG滴度升高与脱颗粒频率增加、血嗜酸性粒细胞增多、痰总细胞数增加、外周血白细胞增多及淋巴细胞减少相关。
  • 相关细胞因子包括IL-15(OR 1.79,CI 1.19-2.70)、IL-13(OR 1.06,CI 1.02-1.12)和IL-12p70(OR 3.34,CI 1.32-8.40)。
  • 抗MARCO抗体阳性患者后续感染性急性加重风险高于嗜酸性急性加重(P=0.01)。
  • 用免疫沉淀免疫球蛋白(抗MARCO+痰)处理的MDM细菌摄取减少39%±15%,LPS刺激后IL-10和GM-CSF释放显著减少(P<0.05)。

临床怎么用

  • 对重度哮喘患者,尤其混合粒细胞痰者,可关注抗MARCO IgG以识别感染性急性加重高风险人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Localized autoimmune responses have been reported in patients with severe eosinophilic asthma, characterized by eosinophil degranulation and airway infections. Objective: To determine the presence of autoantibodies against macrophage scavenger receptors within the airways and their effects on macrophage function and susceptibility to infection. Methods: Anti-EPX (eosinophil peroxidase), anti-MARCO (macrophage receptor with collagenous structure) IgG titers, and T1 and T2 (type 1/2) cytokines were measured in 221 sputa from 143 well-characterized patients with severe asthma. Peripheral monocytes and MDMs (monocyte-derived macrophages) isolated from healthy control subjects were treated with immunoprecipitated immunoglobulins from sputa with high anti-MARCO titers or nonspecific IgG to assess uptake of Streptococcus pneumoniae or response to the bacterial product LPS. Measurements and Main Results: Anti-MARCO IgG was detected in 36% of patients, with significantly higher titers (up to 1:16) in patients with mixed granulocytic sputa, indicative of airway infections. Multivariate regression analysis confirmed increased frequency of degranulation (free eosinophil granules), increased blood eosinophils (indicative of high T2 burden), increased sputum total cell count, peripheral blood leukocytes (indicative of infection), and lymphopenia were associated with increased anti-MARCO IgG titers; IL-15 (odds ratio [OR], 1.79; confidence interval [CI], 1.19-2.70), IL-13 (OR, 1.06; CI, 1.02-1.12), and IL-12p70 (OR, 3.34; CI, 1.32-8.40) were the associated cytokines. Patients with anti-MARCO antibodies had higher chances of subsequent infective versus eosinophilic exacerbations (P = 0.01). MDMs treated with immunoprecipitated immunoglobulins (anti-MARCO+ sputa) had reduced bacterial uptake by 39% ± 15% and significantly reduced release of IL-10 and granulocyte-macrophage colony-stimulating factor (GM-CSF) (P < 0.05) in response to an LPS stimulus. Conclusions: Autoantibodies against macrophage scavenger receptors in eosinophilic asthma airways may impede effective host defenses and lead to recurrent infective bronchitis.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Son K, Miyasaki K, Salter B, et al. Autoantibody-mediated Macrophage Dysfunction in Patients with Severe Asthma with Airway Infections. Am J Respir Crit Care Med. 2023. PMID: 36287613. doi:10.1164/rccm.202206-1183OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。